ContextVision AB: Q1 interim report 2024 – Building for the future and leading innovation

Q1 Highlights Participation in the European Congress of Radiology in Vienna meeting new potential customers and following up on previous discussions with potential customers. Celebrating 25 years of partnership with a customer, underscoring our commitment to long-lasting relationships and techological leadership. Rebuilding of the internal product development structure to enable faster and more frequent product […]
Read More

ContextVision publishes annual report for the fiscal year 2023

The annual report is available in both Swedish and English versions. The report is best suited for reading on screen. Printed copies can be ordered via ContextVision also registers the ESEF version (European Single Electronic Format) of the annual report for 2023 with the Swedish Financial Supervisory Authority. For more information, please contact: Richard […]
Read More

ContextVision AB: Year-end report 2023 – Underlying growth and scaling up the business

Q4 Highlights New advanced X-ray product Altumira™ Plus with scatter correction released Participation in world’s largest medical imaging conference, Radiological Society of North America (RSNA) Increasing interest from customers and OEMs in our products Strategic investments in Point of Care Ultrasound (POCUS), R&D and Quality Management Q4 Financial Data Record Q4 Net Sales of 33.2 […]
Read More

Annual report 2022 – record sales with full focus on growing the core business

STOCKHOLM – March 30th, 2023 – ContextVision, a medical technology software company specializing in image processing and image analysis, today presents their Annual Report for 2022. The Annual Report gives additional information about the record year, where net sales increased by 20% compared to 2021, and EBITDA ended at 49 MSEK or 42%. 2022 was […]
Read More

Successfully focusing on core business

STOCKHOLM – 11 of August 2022 – ContextVision, a medical technology software company specializing in image processing, delivered the Company’s best ever second quarter revenue numbers and a significant EBITDA increase. Sales in the second quarter reached MSEK 32,5 (24.4), an 19% increase compared with the previous quarter, and an increase of 26% versus last year’s […]
Read More